"AI-native solutions that make healthcare simpler" is a generic claim every EHR vendor makes with "AI" swapped in
A comprehensive pharmacotherapy review of HSDD treatments in premenopausal women has positioned bremelanotide within the evolving therapeutic landscape alongside flibanserin, highlighting its distinct mechanism, on-demand subcutaneous dosing paradigm, and favorable safety profile (PMID: 38767282)
They may be prescribed when a clinician determines that a compounded preparation is appropriate, but they should not be described as generic versions of Wegovy or Zepbound
These are all important conversations to have, of course
if given together FBC monitoring should continue during and for at least 2 months after stopping therapy Hepatic Toxicity: Risk increased with alcohol, retinoids & related compounds (acitretin/etretinate/isotretinoin), sulphasalazine, leflunomide, fluconazole, statins, terbinafine and tamoxifen Nephrotoxicity: Increased with nephrotoxic chemotherapy (e.g
These observations, combined with the fact that GLP-1 receptors are present in brain regions involved in reward processing, suggested that the drugs might influence cravings